Spring direct naar de hoofdnavigatie of de inhoud
‘In the end it's all about the value that the patent adds to the product.’
Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

Continue reading

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

Also see these experts

Annemiek Tepper

Annemiek Tepper

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
Sjoerd Postma

Sjoerd Postma

  • European and Dutch Patent Attorney, European Patent Litigator
  • Associate
More experts

News

Romania joined UPC as of 1 September

Having signed the UPC agreement on 31 May this year, Romania officially joined as of 1  September.Continue reading

Watch your language in patent proceedings

In many situations patent law may require that translations be made, for example of patents or prior art documents. Among other things, the advent of the unitary patent added new translation requirements. In this regard, it is notable that computer translations are expressly not allowed. Good to be aware of this.Continue reading

The UPC is one year old

The Unified Patent Court (UPC) is a new European court specialized in patent litigation. It currently has jurisdiction in 17 European countries and Romania will join as the 18th country by 1 September 2024. Its start on 1 June 2023 marks a milestone in the European IP landscape. What can be learned from the first […]Continue reading

Events

IPO Annual Meeting 2024

Hyatt Regency Chicago, East Wacker Drive, Chicago, Illinois, USA

The IPO Annual Meeting offers a mix of educational programs featuring leaders in the IP industry, committee meetings, networking opportunities, sponsors, exhibitors, and more.

Continue reading

Meet your co-founder XL

Bar Brasserie NEXT, Noord Brabantlaan, Eindhoven, Netherlands

Find the right co-founder to build your startup! Meet Your Co-Founder XL is a live national matchmaking event to find a promising tech start-up to join or to find a co-founder that can strengthen your tech company.

Continue reading

2024 AIPPI World Congress

Hangzhou International Expo Center, Benjing 2nd Road, Xiaoshan District, Hangzhou, Zhejiang, China

The annual AIPPI Wereldcongres, held in September or October, is the one moment in the year when members from all around the world come together to discuss hot topics in Intellectual Property. Usually, up to 2000 members attend with accompanying persons.

Continue reading